The global seasonal allergy industry is poised for significant growth, projected to expand from USD 1.22 billion in 2023 to USD 2.58 billion by 2033, at a robust compound annual growth rate (CAGR) of 7.8%, according to a recent report by Future Market Insights. Tablets and capsules, the leading form of treatment, commanded approximately 37.1% …